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ABSTRACT
Objective: To review critically and to summarize the evidence of diagnostic tests and culture media
for the diagnosis of Trichomonas vaginitis.
Methods: We performed a systematic review of literature indexed in MEDLINE of studies that
used Trichomonas culture as the reference standard (9,882 patients, 35 studies). Level I studies
(5,047 patients, 13 studies) fulfilled at least two of three criteria: 1) consecutive patients were
evaluated prospectively, 2) decision to culture was not influenced by test results, and 3) there was
independent and blind comparison to culture.
Results: The sensitivity of the polymerase chain reaction technique (PCR) was 95% (95% CI
91% to 99%), and the specificity was 98% (95% CI 96% to 100%). One study was classified as Level
I evidence (52 patients). The sensitivity of the enzyme-linked immunosorbent assay was 82% (95%
CI 74% to 90%), and the specificity was 73% (95% CI 35% to 100%). The sensitivity of the direct
fluorescence antibody was 85% (95% CI 79% to 90%), and the specificity was 99% (95% CI 98%
to 100%). Sensitivities of culture media were 95% for Diamond’s, 96% for Hollander, and 95% for
CPLM.
Conclusions: The sensitivity and specificity of tests to diagnose trichomoniasis vary widely. Infect.
Dis. Obstet. Gynecol. 8:248-257, 2000. (C) 2000 Wiley-Liss, Inc.
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new cases each year worldwide, 8 million of which
occur in the United States. 1-3 Trichomonas vaginalis
infection leads to symptomatic vaginitis and con-
tributes to preterm labor, perinatal morbidity, and
possible cervical dysplasia.4-7 Moreover, trichomo-
niasis increases the risk of transmission of the hu-
man immunodeficiency virus by twofold.8 Accu-
rate, reliable, convenient, and inexpensive
diagnostic tests are essential to reduce the inci-
dence and impact of this important pathogen. Cur-
rently, the most convenient and widely used diag-
nostic test for trichomoniasis is the wet mount.6,9,1
A positive wet mount is diagnostic because of its
high specificity, whereas a negative test cannot ex-
clude trichomoniasis because of its low sensitiv-
ity.9,11, az
Vaginal culture is considered the best test for
the diagnosis of trichomoniasis and is the current
reference standard.6,1,13-s The swab of the
sample is immersed in culture broth and incubated
at 37C to maximize growth. Specimens are ob-
served microscopically for presence of motile or-
ganisms; if no growth is observed, usually by 7
days, the culture is said to be negative. Unfortu-
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nately, culture media are not widely available to
the practicing physician, requiring 2-7 days to ob-
tain results. The InPouch TV, 16 a technique that
has recently received attention, is a commercially
available medium consisting of a two-chambered
bag that allows culture and microscopic examina-
tion of the specimen. Other tests to identify Tricho-
monas include polymerase chain reaction (PCR),
enzyme-linked immunoassay (ELISA), direct fluo-
rescence antibody assay (DFA), enzyme immuno-
assay (EIA), dot-immunobinding (DIBA) assay,
indirect fluorescent antibody (IFA) assay, aggluti-
nation test (AT), and stained smear techniques
(Pappenheim stain, Papanicolaou smear).6 The lat-
ter tests were not mentioned in the 1998 Center of
Disease Control and Prevention (CDC) guidelines
for the treatment of sexually transmitted dis-
eases17; currently, no guideline regarding the diag-
nosis of trichomoniasis is available.
Clinical investigations may result in inaccurate
estimates of sensitivity and specificity if: 1).no ref-
erence standard is used, 2) patients are not evalu-
ated prospectively, 3) the test result or reference
standard influences the decision to perform the
comparison test, or 4) the tests are not examined
blindly and independently, is-el In a recent meta-
analysis of the wet mount and Papanicolaou smear
for the diagnosis of trichomoniasis, Wiese et al. lz
found that 74 of 104 studies did not use a reference
standard. Although several investigations have sug-
gested the utility of other diagnostic tests for
trichomoniasis, their methodologic validity has not
been critically examined. We conducted a system-
atic review of other diagnostic tests for Trichomonas
vaginitis in order to obtain overall estimates of test
sensitivity and specificity. In addition, we reviewed
the accuracy of various culture media. Our system-
atic review of the evidence may help with devel-
opment of guidelines for the diagnosis of trichomo-
niasis.
SUBJECTS AND METHODS
We searched the MEDLINE database in all lan-
guages for articles published between January,
1976, and November, 1998, describing diagnostic
tests for vaginal trichomoniasis in humans (Ovid
7.05; Ovid, Technologies Inc., New York, NY).
The key words to identify trichomoniasis were: ex-
plode (exp) Trichomonas, exp Trichomonas infec-
tions, Trichomonas vaginalis, and Trichomonas vagi-
nitis. Any terms under each subheading were also
retrieved. The text word Trichomonas and the wild-
card word trichomon$ were also searched. The key
words to identify diagnostic tests were: exp sensi-
tivity and specificity, exp diagnostic errors, diag-
nostic tests routine, multiphasic screening, likeli-
hood functions, diagnosis-differential, false-
positive reactions, exp false-negative reactions, exp
diagnosis, receiver operating curve, sensitivity (text
word), and specificity (text word), zz,z3 References
listed in these published studies and in recent re-
view articles were retrieved. 6,13,z4 The search
yielded 584 articles. We used Biblio-Link II and
Procite software (Research Information Systems,
Carlsbad, CA) to catalog references.
Two investigators reviewed each title and ab-
stract independently to screen for eligible studies.
Articles were reviewed entirely when agreement
on eligibility could not be resolved by consensus
among four investigators. We excluded 436 articles:
402 did not describe diagnostic tests, and 34 lacked
a reference standard. The kappa regarding the ap-
propriateness of exclusion was 0.71. Values of
kappa reflect agreement that is slight (0 to <0.2),
fair (0.2 to <0.4), moderate (0.4 to <0.6), substantial
(0.6 to <0.8), or almost perfect (0.8 to 1).zs
Two investigators independently examined the
remaining 148 articles. We excluded 113 articles
without disagreement: Fifty did not describe diag-
nostic tests, 12 could not be translated (written in
Slovak, Polish, Russian, Korean, or Czech), 43
lacked a reference standard, and eight pertained to
the wet mount or the Papanicolaou smear. Thus,
we selected 35 articles for analysis. 11,6,z6-s8 We
had no disagreement regarding the inclusion of ar-
ticles. One publication used two study designs.
QuailW Criteria for ValidiW of Studies
The reference standard was trichomonads culture
in one or more media with/without the wet mount;
i.e., trichomonas was said to be present when the
organism was identified in one or more culture me-
dia or when the motile organism was seen in the
wet mount. The wet mount alone was not consid-
ered a reference standard. We included only stud-
ies that sampled the vagina (Table 1). Culture me-
dia reviewed either were prepared in the individual
laboratories or were commercially available (such as
Diamond’s medium from Carr Scarborough Micro-
biologicals, Stone Mountain, GA; InPouch TV
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TABLE I. Summary of studies included in the metaanalysis
Quality Disease Sample
criteria prevalence size
Reference Year satisfied Setting
2 (%) (n) Reference standard
Level
Boeke et al. (26)
Sharma et al. (27)
Beal et al. (28)
Briselden et al. (29)
Levi et al. (16)
Jeremias et al. (30)
Krieger et al. (3 I)
Schmid et al. (32)
Bickley et al. (I I)
de Carli et al. (33)
Watt et al. (34)
Philip et al. (35)
Spence et al. (36)
Subtotal
Level II
Madico et al. (37)
Shaio eta. (38)
Yule et al. (39)
I_in et al. (40)
Carney et al. (41)
Draper et al. (42)
DeMeo et al. (43)
Heine et al. (44)
Schwebke et al. (45)
Smith et al. (46)
Imandel et al. (47)
Gelbart et al. (48)
Garber et al. (49)
Thomason et al. (50)
Gombosova et al. (5 I)
Subtotal
Level III
Ohliemeyer et al. (52)
Mason (53)
s (54)
Lisi et al. (55)
Bozner et al. (56)
Weinberger et al. (57)
Romia et al. (58)
Sharma et al. (27)
Subtotal
Total
993 I, 2 General clinic 6 667 CPLM (cervical, vaginal)
991 I, 2 Specialty clinic 7 1,000 Diamond, wet mount
992 I, 2 Specialty clinic 9 710 Oxoid, Hollander, wet mount
994 I, 2, 3 STD clinic 9 170 Diamond, wet mount
997 I, 2 STD clinic 10 715 Diamond, InPouch TV
994 I, 2 General clinic 12 52 Diamond
988 2, 3 STD clinic 15 600 Diamond, Feinberg Wittington
989 I, 2 STD clinic 27 375 Diamond, Kupferger-Trichosel,
Kupferger-STS, Difco-Kupferger, Lash
1989 I, 2, 3 STD clinic 37 104 Diamond, wet mount
1987 I, 2 STD clinic 38 200 Diamond, wet mount
1986 I, 2 STD clinic 47 177 Diamond
1987 I, 2 STD clinic 49 177 Diamond, wet mount
1980 I, 2, 3 STD clinic 50 100 Hollander, wet mount
16 5,047
988 2 General clinic 7 350 InPouch TV
997 2 Specialty clinic 8 378 Agar
987 2 STD clinic 9 482 Diamond
997 2 Specialty clinic 10 165 Agar
988 2 Specialty clinic II 395 Oxoid, wet mount
993 2 Specialty clinic 15 232 Diamond, InPouch TVs, wet mount
996 2 General clinic 15 615 Diamond, wet mount
997 2 STD clinic 16 300 Trichosel broth, wet mount
997 2 STD clinic 26 100 InPouch TV5, wet mount
986 2 STD clinic 30 105 Hollander
985 2 Specialty clinic 30 125 Oxoid, diphasic egg, Merck, wet mount
989 2 Specialty clinic 32 163 Diamond, Kupferger, wet mount
987 2 STD clinic 41 227 Diamond, McCoy cell
988 2 General clinic 42 88 Kupferger, Hirsh, wet mount
990 2 Not described 78 245 Diamond
20 3,970
1998 General clinic 13 268 Diamond
1979 Specialty clinic 26 200 Agar
1982 STD clinic 44 54 Diamond
1988 General clinic 55 66 Feinberg Wittington, wet mount
1992 General clinic 57 49 Diamond
1993 Specialty clinic 73 60 Diamond, wet mount
1991 Specialty clinic 79 118 Diamond, wet mount
1991 Specialty clinic 98 50 Diamond
42 865
20 9,882
Criteria: I, prospective evaluation of consecutive patients; 2, test results did not influence the decision to perform trichomonas culture; 3, test and
trichomonas culture were examined independently and blindly.
2Specialty clinic, urology, obstetrics, gynecology, parasitology; STD, sexually transmitted diseases.
3Same article which used two study designs.
4CPLM (cysteine-peptone-liver medium).
SlnPouch TV (proteose-peptone-medium).
from Bio Med Diagnostics Inc., Santa Clara, CA;
Trichosel broth from Becton-Dickinson Microbiol-
ogy Systems, Cockeysville, MD).
Studies were classified as Level I when they
explicitly fulfilled at least two of three validity cri-
teria: 1) consecutive patients were evaluated pro-
spectively, 2) the test result did not influence the
decision to perform the reference standard, and 3)
the test of interest and reference standard were
blinded and independently examined (Table 2). is
Studies that fulfill these methodologic criteria are
more likely to provide accurate estimates of sensi-
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TABLE 2. Level of Evidence
Methodologic criteria
A reference standard is used
Consecutive patients are evaluated prospectively
Test result does not influence the decision to perform the
reference standard
Test and reference standard are examined blindly and
independently
Level Reference standard and two or more other criteria
Level I1: Reference standard and one other criterion
Level II1: Reference standard
tivity and specificity,
is Studies were classified as
Level II or III, respectively, when any one, or
none, of the criteria was fulfilled.
The articles were randomly distributed among
raters with expertise in evidence-based medicine.
Two raters independently abstracted validity crite,
ria and data from 2 2 contingency tables. Dis-
agreement was resolved by consensus among four
raters examining the full article. The kappa inter-
rater agreement for the three study validity criteria
were 0.48 for consecutive patient evaluation, 0.17
for influence to perform the reference standard,
and 0.61 for test and reference standard indepen-
dent evaluation.
Statistical Analysis
Prevalence, sensitivity, specificity, positive and
negative predictive values, and likelihood ratios
were calculated. Homogeneity of sensitivity and
specificity between studies was explored with the
X
2 test.59-61 Studies were considered homogeneous
when the result of an individual study was math-
ematically compatible with the results of any of the
others. We used a random-effects model to pool
estimates of sensitivity and specificity,
s9 Statistical
methods are not available to pool likelihood ratios,
so a weighted likelihood ratio could not be calcu-
lated. 18,6-6s We calculated an overall likelihood
ratio positive (LR+) by using pooled estimates of
sensitivity and specificity, LR sensitivity/(1
specificity). SPSS 8.0 software was used to perform
statistical analyses (SPSS Inc., Chicago, IL).
RESULTS
Overall, 31% of diagnostic test studies utilized a
reference standard (35/112 studies; Table 1). The
validity criteria were reported in 33% of studies for
consecutive patients and were evaluated prospec-
tively; 78% of studies for the test result did not
influence the decision to perform trichomonas cul-
ture as a reference standard; and 11% of studies for
the cultures were examined independently and
blindly. Table shows the characteristics of the 35
articles (9,882 patients); one publication used two
study designs. Thirteen studies (36%) were classi-
fied as Level (5,047 patients), 15 (42%) as Level
II (3,970 patients), and eight (22%) as Level III
(865 patients). No consistent details of patient in-
formation across studies were available from the
original papers. Asymptomatic patients accounted
for 11% of the reports, patients with/without symp-
toms 64% (no breakdown of estimates among
groups provided), and the remainder of the reports
did not specify whether patients were symptomatic
or not.
PCR Technique
Six studies examined the test characteristics of the
PCR (1,973 patients; Table 3). The pooled sensi-
tivity was 95% (95% CI 91% to 99%), the pooled
specificity was 98% (95% CI 96% to 100%), and the
LR was 48. One study was classified as Level I (52
patients), five as Level II (1,921 patients), and
none as Level III. The overall estimates of sensi-
tivity were homogeneous. The overall estimates of
specificity were heterogeneous.
ELISA
Five studies examined the test characteristics of
the ELISA technique (806 patients; Table 3). The
pooled sensitivity was 82% (95% CI 74% to 90%),
the pooled specificity was 73% (95% CI 35% to
100%), and the LR was 3. One study was classi-
fied as Level (177 patients), one as Level II (395
patients), and three as Level III (234 patients).
The overall estimates of sensitivity and specificity
were heterogeneous.
DFA Technique
Three studies examined the test characteristics of
the DFA technique (809 patients; Table 3). The
pooled sensitivity was 85% (95% CI 79% to 90%),
the pooled specificity was 99% (95% CI 98% to
100%), and the LR was 85. Two studies were clas-
sified as Level I (704 patients), one as Level II (105
patients), and none as Level III. The overall esti-
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TABLE 3. Accuracy of tests to diagnose Trichomonas Vaginitis
Sensitivity Specificity
Prevalence
Test/reference Level (%) Percent (n/n) Percent (n/n)
Likelihood Likelihood Positive Negative
ratio ratio predictive predictive
positive negative value (%) value (%)
PCR
Jeremias et al.
(30) 12 100 (6/6) 98 (45/46)
Madico et al. (37) II 7 96 (22/23) 95 (310/327)
Shaio et al. (38) 8 100 (3 I/3 I) 100 (347/347)
Shaio et al. (38) II 8 100 (9/9) 100 (104/104)
Lin et al. (40) II 10 100 (I 6/16) 100 (149/149)
DeMeo et al. (43) II 15 89 (85/95) 100 (519/520)
Heine et al. (44) II 16 90 (44/49) 95 (239/25 I)
Pooled total 95 98*
95% CI 91to 99 96 to 100
Range 8 to 16 89 to 100 95 to 100
ELISA
Watt et al. (34) 47 77 (65/84) 100 (93/93)
Carney et al. (41) II II 95 (40/42) 99 (351/353)
Lisi et al. (55) III 55 89 (32/36) 97 (29/30)
Romia et al. (58) III 79 75 (70/93) 60 (15/25)
Sharma et al. (27) III 98 76 (37/49) 0 (0/I)
Pooled total 82* 73*
95% CI 74 to 90 35 to 100
Range II to 98 75 to 95 0 to 100
DFA
Krieger et al.
(31) 15 86 (76/88) 99 (509/512)
Bickley et al. (I I) 37 84 (32/38) 98 (65/66)
Smith et al. (46) II 30 81 (25/31) 99 (73/74)
Pooled total 85 99
95% CI 79 to 90 98 to 100
Range 15 to 37 81 to 86 98 to 99
EIA; Yule et al. (39) II 9 93 (41/44) 98 (429/438)
Pappenheim stain;
Garber et al. (49) II 41 83 (77/93) 99 (I 32/134)
DIBA; Gombosova
et al. (5 I) II 78 92 (I 75/191) 93 (50/54)
IFA; Mason (53) III 26 92 (48/52) 62 (92/148)
IFA; Romia et al.
(58) III 79 87 (81/93) 80 (20/25)
IFA, IgA; Su (54) III 44 8 (2/24) 100 (30/30)
IFA, IgE; Su (54) III 44 13 (3/24) 100 (30/30)
IFA, IgG; Su (54) III 44 71 (17/24) 77 (23/30)
IFA, IgM; Su (54) III 44 4 (I/24) 100 (30/30)
AT; Romia et al.
(58) III 79 65 (60/93) 96 (24/25)
46 0.00 86 100




465 0.11 99 98
19 0.11 79 98
19to 0to 0.11 79to 100 98to 100
0.23 100 83
168 0.05 95 99
27 0.11 97 88
2 0.41 88 39
97 0
Ito 0.05to0.41 88tol00 0to99
147 0.14 96 98
56 0.16 97 92
60 0.20 96 92
56to 147 0.14to0.20 96to97 92to98
45 0.07 82 99
55 0.17 97 89
12 0.09 98 76
2 0.12 46 96
4 0.16 94 63
0.92 100 58
0.88 100 59
3 0.38 71 77
0.96 100 57
16 0.37 98 42
Symptomatic patients.
2Asymptomatic patients.
*Denotes heterogeneity of data (P < 0.05).
mates of sensitivity and specificity were homoge-
neous.
Other Techniques
Six studies examined nine other techniques (Table
3). The sensitivities ranged from 4% to 93%, and
the specificities ranged from 62% to 100%. The
LR ranged from 2 to infinity. No studies were
classified as Level I, three as Level II, and three as
Level III.
Culture Media
Twenty studies examined the test characteristics of
11 culture media techniques (Table 4). The pooled
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Levi et al. (I 6)
Schmid et al. (32)
Schmid et al. (32)
Bickley et al. (I I)
de Carli et al. (33)
Philip et al. (35)
Draper et al. (42)
DeMeo et al. (43)
Garber et al. (49)





Beal et al. (28)





Boeke et al. (26)





Levi et al. (16)
Draper et al. (42)
Schwebke et al. (45)
Schwebke et al. (45)





Beal et al. (28)
Carney et al. (41)
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Diphasic egg; Imandel et al. (47)
Hirsh; Thomason et al. (50)
McCoy cell; Garber, et al. (49)



























6 92 to 97
I0 82 (61/74)
! 5 88 (30/34)
II 26 85 (22/26)
II 26 88 (23/26)
III 13 81 (29/36)
84
79 to 89
7 to 26 81 to 88
9 89 (55/62)
II II 76 (32/42)
II 30 81 (30/37)
83
76 to 90
9 to 30 76 to 89
27 75 (77/102)
II 32 77 (40/52)
II 42 86 (32/37)
78
72 to 85
27 to 42 75 to 86
II 30 76 (28/37)
II 30 89 (33/37)
II 42 81 (30/37)
II 60 96 (52/54)




Diamond-modified. 2Cervix sampling. 3Self-collected sample. 4Collected by physician. *Denotes heterogeneity of data (P < 0.05).
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sensitivity for all studies was 90% (95% CI 87% to
93%). The Diamond’s culture medium was exam-
ined in 10 studies (3,568 patients; Table 4). The
pooled sensitivity was 95% (95% CI 93% to 98%).
Six studies were classified as Level I (2,571 pa-
tients), three as Level II (937 patients), and one as
Level III (60 patients). The overall estimates of
sensitivity were heterogeneous.
The Hollander culture medium was examined
in two studies (810 patients; Table 4). The pooled
sensitivity was 96% (95% CI 93% to 100%). Both
studies were classified as Level I. The overall es-
timates of sensitivity were homogeneous.
The CPLM culture medium was examined in
one study (667 patients; Table 4). The pooled sen-
sitivity was 95% (95% CI 80% to 100%). Both stud-
ies were classified as Level I. The overall estimates
of sensitivity were homogeneous.
The InPouch TV technique was examined in
four studies (1,315 patients; Table 4). The pooled
sensitivity was 84% (95% CI 79% to 89%). One
study was classified as Level I (715 patients), two
as Level II (332 patients), and one as Level III (268
patients). The overall estimates of sensitivity were
homogeneous.
DISCUSSION
We performed a systematic review of tests compar-
ing to a reference standard to help with the devel-
opment of guidelines for the diagnosis of trichomo-
niasis. Ideally a test should have high sensitivity
and specificity and be easily available, simple to
perform, and inexpensive. Currently, for the diag-
nosis of trichomoniasis, the wet mount is the least
costly to perform, yet its sensitivity is poor. In the
latest guidelines for the treatment of sexually trans-
mitted diseases, the CDC reports that "The motile
T. vagina/is is identified easily in the saline speci-
men [and] culture for T. vaginalis is more sensitive
than microscopic examination. ’’17 However, no
guidance was provided regarding other diagnostic
tests.
This systematic review shows that PCR for the
diagnosis of trichomoniasis has high sensitivity,
specificity, and LR+. The narrow confidence inter-
vals indicate consistent results between studies.
However, most of the data were derived from
Level II studies. Self-collection of the specimen
66
and rapid results4 are some of the advantages of
this technique. Women with asymptomatic tricho-
moniasis serve as a reservoir for continuing disease
transmission. Therefore, perhaps PCR would be
most useful in mass screening of trichomoniasis,
similarly to its use in the detection of Chlamydia
trachomatis.67 Detection of nonviable organisms in
patients previously treated and unavailability in
most institutions are presently some of the limita-
tions of the PCR technique. In the future, PCR
may be superior to culture. Other techniques such
as ELISA and DFA have lower sensitivities com-
pared to PCR or culture.
Our study raises an important issue: What
should the culture reference standard be for the
diagnosis of vaginal trichomoniasis? Our systematic
review shows that the Diamond, Hollander, and
CPLM culture media seem to be the most accu-
rate, with sensitivities over 95%. Therefore, they
could be used as reference standards. Among these,
Diamond’s medium produces the maximal Tricho-
monas growth in vitro.68 Other culture media have
lower sensitivities and so probably should not be
used as reference standards. Some authors have
recommended selective media (Diamond’s, Tri-
chosel, Hollanders, InPouch TV) as superior for
culture of Trichomonas,6’1 whereas others have
not. 1"3-1s All of the Level I studies included in this
study utilized one of the culture media with the
highest sensitivities (Diamond, Hollander,
CPLM). Although the cost of these culture media
is not high, most practicing physicians are not
aware of their existence, and few hospitals have
them available. Cultures could detect tricho-
monads at 48-72 hr, but it may take up to 7 days to
obtain the final result. A delay in therapy while
waiting for results is not desirable. Trichomonas cul-
ture should be used when the wet mount is nega-
tive and the clinical suspicion is still present. Cul-
ture should also be obtained to confirm a positive
Papanicolaou smear in settings of low to interme-
diate prevalence, lz The estimates of sensitivity for
culture should be interpreted cautiously. The ref-
erence standard in some studies was the culture
medium itself with the wet mount, which may
yield higher estimates of sensitivity for the culture,
whereas in other studies the reference standard was
multiple culture media with/without the wet
mount, which may yield lower estimates of sensi-
tivity. As an example, the sensitivity of the Dia-
mond’s medium ranged from 95% to 99% for the
former scenario and 88% to 97% for the latter.
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Our systematic review has several strengths. We
used a systematic approach in the evidence-based
framework, including studies that utilized a refer-
ence standard. Studies without a reference stan-
dard when one exists are uninterpretable. We also
used explicit validity criteria to assess the level of
the evidence, ls,19 Finally, multiple raters ab-
stracted data to avoid observation bias. Our study
has certain limitations. The methodologic quality
criteria in the studies were not always explicitly
described, resulting in less-than-ideal interrater
agreements. We address this by discussing the cri-
teria among four authors but acknowledge that
other reviewers might reach different decisions.
The study design was not uniform among reports,
and not all estimates were homogeneous. We used
a random-effect model to attempt to correct for
heterogeneity among such studies,s9 but we cau-
tion the reader to examine the primary data instead
of the pooled estimates.
In summary, PCR is a promising technique with
sensitivity equal to or better than that of culture.
However, more Level studies are needed. The
CDC should make a uniform recommendation
with the appropriate reference standard for the di-
agnosis of trichomoniasis. In the meantime, it
seems prudent to use only the culture media with
the highest sensitivity as a reference standard (Dia-
mond, Hollander, or CPLM).
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